COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2089.0 | 9 | 0327-0664 | 162.23 | 664.66 | 252 | 61.94 | 0.825 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1837.8 | 9 | 0328-0670 | 140.52 | 670.03 | 284 | 64.18 | 0.866 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1631.1 | 9 | 0329-0672 | 297.72 | 672.30 | 288 | 66.43 | 0.820 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3235.3 | 9 | 0330-0674 | 875.21 | 673.40 | 244 | 60.53 | 0.837 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3197.5 | 9 | 0331-0676 | 380.69 | 676.33 | 270 | 67.84 | 0.737 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 4106.6 | 9 | 0332-0675 | 91.03 | 674.87 | 253 | 59.60 | 0.895 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 6059.3 | 9 | 0333-0676 | 937.72 | 675.75 | 245 | 59.11 | 0.881 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 6003.3 | 9 | 0334-0674 | 786.59 | 674.75 | 198 | 50.87 | 0.962 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1952.6 | 9 | 0335-0684 | 887.77 | 684.20 | 229 | 60.77 | 0.779 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1285.3 | 9 | 0336-0686 | 264.85 | 686.00 | 246 | 60.53 | 0.844 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2893.9 | 9 | 0337-0692 | 837.75 | 693.34 | 241 | 64.43 | 0.730 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1815.4 | 9 | 0338-0695 | 451.42 | 695.09 | 247 | 59.60 | 0.874 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1263.3 | 9 | 0339-0698 | 629.42 | 698.59 | 368 | 72.43 | 0.882 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2427.0 | 9 | 0340-0696 | 691.70 | 698.16 | 252 | 70.43 | 0.638 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3972.7 | 9 | 0341-0695 | 937.50 | 695.64 | 242 | 57.11 | 0.932 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1331.0 | 9 | 0342-0697 | 110.29 | 698.24 | 232 | 66.18 | 0.666 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2171.5 | 9 | 0343-0703 | 749.84 | 702.22 | 218 | 59.11 | 0.784 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 5197.2 | 9 | 0344-0703 | 45.50 | 703.45 | 308 | 66.43 | 0.877 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1678.0 | 9 | 0345-0708 | 150.33 | 708.96 | 334 | 70.43 | 0.846 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 584.6 | 9 | 0346-0706 | 185.63 | 705.56 | 275 | 66.43 | 0.783 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2777.5 | 9 | 0347-0703 | 907.57 | 703.18 | 102 | 37.80 | 0.897 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3160.8 | 9 | 0348-0708 | 216.50 | 709.43 | 226 | 57.36 | 0.863 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2659.3 | 1 | 0001-0025 | 822.14 | 25.96 | 373 | 78.43 | 0.762 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 3337.1 | 1 | 0002-0032 | 681.57 | 32.38 | 336 | 70.18 | 0.857 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1347.5 | 1 | 0003-0031 | 209.13 | 31.38 | 259 | 59.94 | 0.906 |